US Stock MarketDetailed Quotes

HURA TuHURA Biosciences

Watchlist
  • 3.230
  • -0.300-8.50%
Close Mar 31 16:00 ET
136.70MMarket Cap-2.76P/E (TTM)

About TuHURA Biosciences Company

TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company was founded on May 4, 2023 and is headquartered in Tampa, FL.

Company Profile

SymbolHURA
Company NameTuHURA Biosciences
Listing DateJul 12, 2016
Founded2023
CEODr. James A. Bianco,M.D.
MarketNASDAQ
Fiscal Year Ends12-31
Address10500 University Center Drive,Suite 110
CityTampa
ProvinceFlorida
CountryUnited States of America
Zip Code33612
Phone1-813-875-6600

Company Executives

  • Name
  • Position
  • Salary
  • Dr. James A. Bianco,M.D.
  • Chief Executive Officer and Director
  • --
  • Daniel Dearborn
  • Chief Financial Officer
  • --
  • Dr. Dennis Yamashita, PhD
  • Chief Scientific Officer
  • --
  • Robert E. Hoffman, C.P.A.
  • Director
  • --
  • Craig Tendler
  • Director
  • --
  • George K. Ng
  • Independent Director
  • --
  • Dr. James S.J. Manuso, M.B.A.,PhD
  • Independent Director
  • --
  • Dr. Alan List, M.D.
  • Independent Director
  • --

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More